Subhas Chakrabarty, Ph.D.

Print

July 6, 2005

SIU Cancer Institute Names Associate Director for Research Programs

Subhas Chakrabarty, Ph.D., Subhas Chakrabarty, Ph.D., portrait has been recruited as associate director for basic science for the SIU Cancer Institute at Southern Illinois University School of Medicine. He also has an academic appointment as a professor of medical microbiology, immunology and cell biology at the medical school. He joined SIU's faculty in June.

Chakrabarty's primary responsibility is the development of a complete cancer research team, which can compete successfully for external funding. In addition to his administrative duties, he will help teach medical students, resident physicians and graduate students.

"We are very pleased to have recruited Dr. Chakrabarty who will play a key role in the next phase of developing the cancer research program," said Dr. K. Thomas Robbins, interim director of the SIU Cancer Institute. "His outstanding achievements as an National Cancer Institute-funded cancer researcher and his experience at M.D. Anderson Cancer Center are tremendous assets for our expanding cancer program here at SIU. We welcome Subhas to our leadership team."

Chakrabarty will be bringing a five-year grant studying colon cancer from the National Institutes of Health to complete at SIU as well as a new five-year $1.9 million grant studying colon cancer from the National Cancer Institute. His previous grants total $4.4 million.

Most recently, Chakrabarty was an associate professor of molecular pathology and of molecular and cellular oncology at the University of Texas (UT) M.D. Anderson Cancer Center. He also was a member of the graduate school of biomedical sciences at UT.

His previous UT faculty appointments were a joint appointment as an associate biochemist and associate professor of laboratory medicine and of tumor biology (1993-2000) and as an assistant biologist and assistant professor of laboratory medicine and of tumor biology (1990-93). He also was an assistant professor of pharmacology at Baylor College of Medicine in Houston (1984-90).

Chakrabarty was a postgraduate research associate in cancer biology and pharmacology at Baylor (1980-84). He earned his doctorate in immunology at the University of Manitoba Medical School in Winnipeg, Canada (1980), his master’s in microbiology and biochemistry at the University of North Dakota (UND) Medical School in Grand Forks (1974) and his bachelor's degree in biology and psychology at UND (1973). His son, Justin A. Chakrabarty will enter Houston Baptist University this fall.

He is a member of American Society for Cell Biology, American Association for Cancer Research, American Association for the Advancement of Science and Clinical Ligand Assay Society. He serves on the editorial boards for Frontiers in Bioscience (managing editor) and Journal of Clinical Ligand Assay and reviews manuscripts for 15 other oncology and research journals. He has published 81 peer-reviewed and invited journal articles along with seven book chapters.

The SIU Cancer Institute is focusing the medical school's efforts in cancer research, physician and public education, and treatment for patients from across central and southern Illinois. More than 55 SIU physician and basic science faculty are involved.

The SIU Cancer Institute has a web site at http://www.siumed.edu/cancer/. The main phone number is 217-545-6818.


Phone 217-545-8000
P.O. Box 19620
Springfield, IL 62794-9620
The mission of SIU School of Medicine is to assist the citizens of central and southern Illinois in meeting their health-care needs through education, patient care, research and service to the community.

Connect

Connect on FacebookMore About SIU SOM on YouTubeSIU Blogtwitter